• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多支冠状动脉疾病合并糖尿病对人心房心肌和冠状动脉血管周围脂肪组织中内皮和脂蛋白脂肪酶的表达影响相对较小。

Multivessel Coronary Artery Disease Complicated by Diabetes Mellitus Has a Relatively Small Effect on Endothelial and Lipoprotein Lipases Expression in the Human Atrial Myocardium and Coronary Perivascular Adipose Tissue.

机构信息

Department of Cardiology, Medical University of Bialystok, 15-089 Bialystok, Poland.

Department of Physiology, Medical University of Bialystok, Mickiewicza 2C Street, 15-222 Bialystok, Poland.

出版信息

Int J Mol Sci. 2023 Aug 31;24(17):13552. doi: 10.3390/ijms241713552.

DOI:10.3390/ijms241713552
PMID:37686357
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10487606/
Abstract

Endothelial (EL) and lipoprotein (LPL) lipases are enzymes involved in lipoproteins metabolism and formation of atherosclerosis, a pathological feature of coronary artery disease (CAD). This paper examines the role of the lipases in the right atrial appendage (RAA) and coronary perivascular adipose tissue (PVAT) of patients with CAD alone or with accompanying diabetes. Additionally, correlation analysis for plasma concentration of the lipases, apolipoproteins (ApoA-ApoJ) and blood lipids (Chol, HDL-C, LDL-C, TAG) was performed. We observed that CAD had little effect on the lipases gene/protein levels in the RAA, while their transcript content was elevated in the PVAT of diabetic CAD patients. Interestingly, the RAA was characterized by higher expression of EL/LPL (EL: +1-fold for mRNA, +5-fold for protein; LPL: +2.8-fold for mRNA, +12-fold for protein) compared to PVAT. Furthermore, ApoA1 plasma concentration was decreased, whereas ApoC1 and ApoH were increased in the patients with CAD and/or diabetes. The concentrations of ApoC3 and ApoD were strongly positively correlated with TAG content in the blood, and the same was true for ApoB with respect to LDL-C and total cholesterol. Although plasma concentrations of EL/LPL were elevated in the patients with diabetes, CAD alone had little effect on blood, myocardial and perivascular fat expression of the lipases.

摘要

内皮(EL)和脂蛋白(LPL)脂肪酶是参与脂蛋白代谢和动脉粥样硬化形成的酶,动脉粥样硬化是冠心病(CAD)的病理特征。本文研究了这些脂肪酶在 CAD 患者或合并糖尿病患者的右心耳(RAA)和冠状动脉血管周围脂肪组织(PVAT)中的作用。此外,还对脂肪酶、载脂蛋白(ApoA-ApoJ)和血脂(Chol、HDL-C、LDL-C、TAG)的血浆浓度进行了相关分析。我们发现 CAD 对 RAA 中脂肪酶的基因/蛋白水平几乎没有影响,而糖尿病 CAD 患者的 PVAT 中其转录物含量升高。有趣的是,与 PVAT 相比,RAA 表现出更高的 EL/LPL 表达(EL:mRNA 增加 1 倍,蛋白增加 5 倍;LPL:mRNA 增加 2.8 倍,蛋白增加 12 倍)。此外,CAD 和/或糖尿病患者的 ApoA1 血浆浓度降低,而 ApoC1 和 ApoH 增加。ApoC3 和 ApoD 的浓度与血液中的 TAG 含量呈强烈正相关,ApoB 与 LDL-C 和总胆固醇也呈正相关。尽管糖尿病患者的血浆 EL/LPL 浓度升高,但 CAD 本身对血液、心肌和血管周围脂肪组织中脂肪酶的表达影响不大。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1105/10487606/47f5cdd74261/ijms-24-13552-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1105/10487606/d383ed1ada7c/ijms-24-13552-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1105/10487606/a46116786cbd/ijms-24-13552-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1105/10487606/bbfd5ac91e32/ijms-24-13552-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1105/10487606/0b107e5d23d7/ijms-24-13552-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1105/10487606/6ed8ca1bf97f/ijms-24-13552-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1105/10487606/ead8fbfa2fd0/ijms-24-13552-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1105/10487606/47f5cdd74261/ijms-24-13552-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1105/10487606/d383ed1ada7c/ijms-24-13552-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1105/10487606/a46116786cbd/ijms-24-13552-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1105/10487606/bbfd5ac91e32/ijms-24-13552-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1105/10487606/0b107e5d23d7/ijms-24-13552-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1105/10487606/6ed8ca1bf97f/ijms-24-13552-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1105/10487606/ead8fbfa2fd0/ijms-24-13552-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1105/10487606/47f5cdd74261/ijms-24-13552-g007.jpg

相似文献

1
Multivessel Coronary Artery Disease Complicated by Diabetes Mellitus Has a Relatively Small Effect on Endothelial and Lipoprotein Lipases Expression in the Human Atrial Myocardium and Coronary Perivascular Adipose Tissue.多支冠状动脉疾病合并糖尿病对人心房心肌和冠状动脉血管周围脂肪组织中内皮和脂蛋白脂肪酶的表达影响相对较小。
Int J Mol Sci. 2023 Aug 31;24(17):13552. doi: 10.3390/ijms241713552.
2
The Gene and Protein Expression of the Main Components of the Lipolytic System in Human Myocardium and Heart Perivascular Adipose Tissue. Effect of Coronary Atherosclerosis.人心肌和心脏血管周围脂肪组织中脂肪分解系统主要成分的基因和蛋白表达。冠状动脉粥样硬化的影响。
Int J Mol Sci. 2020 Jan 22;21(3):737. doi: 10.3390/ijms21030737.
3
The role of plasma lipoprotein lipase, hepatic lipase and GPIHBP1 in the metabolism of remnant lipoproteins and small dense LDL in patients with coronary artery disease.血浆脂蛋白脂肪酶、肝脂肪酶和 GPIHBP1 在冠心病患者残粒脂蛋白和小而密 LDL 代谢中的作用。
Clin Chim Acta. 2018 Jan;476:146-153. doi: 10.1016/j.cca.2017.11.021. Epub 2017 Nov 22.
4
Serum Triglyceride Lipase Concentrations are Independent Risk Factors for Coronary Artery Disease and In-Stent Restenosis.血清三酰甘油脂肪酶浓度是冠状动脉疾病和支架内再狭窄的独立危险因素。
J Atheroscler Thromb. 2019 Sep 1;26(9):762-774. doi: 10.5551/jat.46821. Epub 2019 Jan 17.
5
Lipoprotein composition in patients with type 1 diabetes mellitus: Impact of lipases and adipokines.1型糖尿病患者的脂蛋白组成:脂肪酶和脂肪因子的影响。
J Diabetes Complications. 2016 May-Jun;30(4):657-68. doi: 10.1016/j.jdiacomp.2016.01.018. Epub 2016 Jan 26.
6
The antagonic behavior of GPIHBP1 between EAT and circulation does not reflect lipolytic enzymes levels in the tissue and serum from coronary patients.GPIHBP1在脂肪组织(EAT)与循环系统之间的拮抗行为并不能反映冠心病患者组织和血清中的脂解酶水平。
Clin Chim Acta. 2020 Nov;510:423-429. doi: 10.1016/j.cca.2020.08.001. Epub 2020 Aug 7.
7
Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. The Ser447-stop substitution in the lipoprotein lipase gene. REGRESS Study Group.在冠状动脉疾病患者中,遗传变异与β受体阻滞剂存在正向相互作用,对脂蛋白脂肪酶活性、高密度脂蛋白胆固醇和甘油三酯水平产生有益影响。脂蛋白脂肪酶基因中的Ser447-stop替代。REGRESS研究组。
Circulation. 1997 Jun 17;95(12):2628-35. doi: 10.1161/01.cir.95.12.2628.
8
[Pathologic decrease in lipoprotein lipase activity in relation to the development of hyperlipemias and their significance for coronary heart disease].[脂蛋白脂肪酶活性病理性降低与高脂血症发生发展的关系及其对冠心病的意义]
Wien Klin Wochenschr Suppl. 1986;167:1-16.
9
Activity and concentration of lipoprotein lipase in post-heparin plasma and the extent of coronary artery disease.肝素后血浆中脂蛋白脂肪酶的活性和浓度与冠状动脉疾病的程度
Atherosclerosis. 2002 Jul;163(1):127-34. doi: 10.1016/s0021-9150(01)00752-3.
10
Lipoprotein lipase gene mutations, plasma lipid levels, progression/regression of coronary atherosclerosis, response to therapy, and future clinical events. Lipoproteins and Coronary Atherosclerosis Study.脂蛋白脂肪酶基因突变、血脂水平、冠状动脉粥样硬化的进展/消退、对治疗的反应以及未来临床事件。脂蛋白与冠状动脉粥样硬化研究。
Atherosclerosis. 1999 Jun;144(2):435-42. doi: 10.1016/s0021-9150(99)00004-0.

本文引用的文献

1
Standardization of Apolipoprotein B, LDL-Cholesterol, and Non-HDL-Cholesterol.载脂蛋白 B、低密度脂蛋白胆固醇和非高密度脂蛋白胆固醇的标准化。
J Am Heart Assoc. 2023 Aug;12(15):e030405. doi: 10.1161/JAHA.123.030405. Epub 2023 Jul 25.
2
Perivascular adipose tissue in vascular pathologies-a novel therapeutic target for atherosclerotic disease?血管病变中的血管周围脂肪组织——动脉粥样硬化疾病的新治疗靶点?
Front Cardiovasc Med. 2023 May 26;10:1151717. doi: 10.3389/fcvm.2023.1151717. eCollection 2023.
3
The role of epicardial adipose tissue dysfunction in cardiovascular diseases: an overview of pathophysiology, evaluation, and management.
心外膜脂肪组织功能障碍在心血管疾病中的作用:病理生理学、评估和管理概述。
Front Endocrinol (Lausanne). 2023 May 16;14:1167952. doi: 10.3389/fendo.2023.1167952. eCollection 2023.
4
Role of apolipoprotein C1 in lipoprotein metabolism, atherosclerosis and diabetes: a systematic review.载脂蛋白 C1 在脂蛋白代谢、动脉粥样硬化和糖尿病中的作用:系统评价。
Cardiovasc Diabetol. 2022 Dec 5;21(1):272. doi: 10.1186/s12933-022-01703-5.
5
The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial.在原发性心血管预防中,患有白蛋白尿的 2 型糖尿病患者的非目标风险因素数量与心血管风险相关。NID-2 试验的事后分析。
Cardiovasc Diabetol. 2022 Nov 7;21(1):235. doi: 10.1186/s12933-022-01674-7.
6
Impact of serum levels of lipoprotein lipase, hepatic lipase, and endothelial lipase on the progression of coronary artery disease.血清脂蛋白脂肪酶、肝脂肪酶和内皮脂肪酶水平对冠状动脉疾病进展的影响。
J Interv Med. 2019 Jun 27;2(1):16-20. doi: 10.1016/j.jimed.2019.05.005. eCollection 2019 Feb.
7
High density lipoprotein in atherosclerosis and coronary heart disease: Where do we stand today?高密度脂蛋白在动脉粥样硬化和冠心病中的作用:我们今天处于什么位置?
Vascul Pharmacol. 2021 Dec;141:106928. doi: 10.1016/j.vph.2021.106928. Epub 2021 Oct 22.
8
Obesity, Adipose Tissue and Vascular Dysfunction.肥胖、脂肪组织与血管功能障碍。
Circ Res. 2021 Apr 2;128(7):951-968. doi: 10.1161/CIRCRESAHA.121.318093. Epub 2021 Apr 1.
9
APOA1: a Protein with Multiple Therapeutic Functions.载脂蛋白 A1:具有多种治疗功能的蛋白质。
Curr Atheroscler Rep. 2021 Feb 16;23(3):11. doi: 10.1007/s11883-021-00906-7.
10
Coronary Artery Disease.冠状动脉疾病
Arterioscler Thromb Vasc Biol. 2020 Jul;40(7):e185-e192. doi: 10.1161/ATVBAHA.120.313608. Epub 2020 Jun 24.